T. Rowe Price Associates’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $458K | Hold |
3,614
| – | – | ﹤0.01% | 2346 |
|
|
2025
Q1 | $463K | Hold |
3,614
| – | – | ﹤0.01% | 2275 |
|
|
2024
Q4 | $478K | Hold |
3,614
| – | – | ﹤0.01% | 2296 |
|
|
2024
Q3 | $527K | Hold |
3,614
| – | – | ﹤0.01% | 2224 |
|
|
2024
Q2 | $497K | Hold |
3,614
| – | – | ﹤0.01% | 2189 |
|
|
2024
Q1 | $496K | Hold |
3,614
| – | – | ﹤0.01% | 2213 |
|
|
2023
Q4 | $491K | Hold |
3,614
| – | – | ﹤0.01% | 2178 |
|
|
2023
Q3 | $442K | Hold |
3,614
| – | – | ﹤0.01% | 2165 |
|
|
2023
Q2 | $459K | Hold |
3,614
| – | – | ﹤0.01% | 2173 |
|
|
2023
Q1 | $467K | Hold |
3,614
| – | – | ﹤0.01% | 2139 |
|
|
2022
Q4 | $474K | Hold |
3,614
| – | – | ﹤0.01% | 2151 |
|
|
2022
Q3 | $423K | Hold |
3,614
| – | – | ﹤0.01% | 2209 |
|
|
2022
Q2 | $425K | Hold |
3,614
| – | – | ﹤0.01% | 2279 |
|
|
2022
Q1 | $471K | Hold |
3,614
| – | – | ﹤0.01% | 2361 |
|
|
2021
Q4 | $552K | Hold |
3,614
| – | – | ﹤0.01% | 2338 |
|
|
2021
Q3 | $584K | Hold |
3,614
| – | – | ﹤0.01% | 2300 |
|
|
2021
Q2 | $591K | Sell |
3,614
-89
| -2% | -$14.6K | ﹤0.01% | 2304 |
|
|
2021
Q1 | $558K | Buy |
3,703
+89
| +2% | +$13.4K | ﹤0.01% | 2313 |
|
|
2020
Q4 | $547K | Buy |
+3,614
| New | +$547K | ﹤0.01% | 2204 |
|